{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:34:21Z","timestamp":1791228861831,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160766"],"award-info":[{"award-number":["82160766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Province Key Laboratory of bioengineering drugs","award":["2024SSY07061"],"award-info":[{"award-number":["2024SSY07061"]}]},{"name":"Youth Fund Project of Jiangxi Provincial Natural Science Foundation","award":["20242BAB20417"],"award-info":[{"award-number":["20242BAB20417"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00850-3","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:34:21Z","timestamp":1773995661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combination of Tripterygium glycosides and Lactobacillus paracasei sensitises epithelial ovarian cancer to cisplatin via downregulating Keap1-Nrf2-GPX4 signalling pathway"],"prefix":"10.1186","volume":"31","author":[{"given":"Meiyun","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6503-8824","authenticated-orcid":false,"given":"Yunyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buzhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"1","key":"850_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"10177","key":"850_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet (London, England). 2019;393(10177):1240\u201353.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"850_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3747\/co.2007.148","volume":"14","author":"M Fung-Kee-Fung","year":"2007","unstructured":"Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P. Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol (Toronto, Ont). 2007;14(5):195\u2013208.","journal-title":"Curr Oncol (Toronto, Ont)"},{"issue":"20","key":"850_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015632","volume":"98","author":"Q Li","year":"2019","unstructured":"Li Q, Kuang HY, Wu YH, Lu TW, Yi QJ. What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: a systematic review and meta-analysis. Med. 2019;98(20):e15632.","journal-title":"Med"},{"issue":"3","key":"850_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40265-013-0019-1","volume":"73","author":"RM Navari","year":"2013","unstructured":"Navari RM. Management of chemotherapy-induced nausea and vomiting: focus on newer agents and new uses for older agents. Drugs. 2013;73(3):249\u201362.","journal-title":"Drugs"},{"issue":"30","key":"850_CR6","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.2217\/fon-2017-0235","volume":"13","author":"S Karakashev","year":"2017","unstructured":"Karakashev S, Aird KM. Ovarian cancer: how can resistance to chemotherapy be tackled? Future Oncol (London, England). 2017;13(30):2737\u20139.","journal-title":"Future Oncol (London, England)"},{"issue":"8","key":"850_CR7","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.ccell.2025.07.005","volume":"43","author":"E Ghisoni","year":"2025","unstructured":"Ghisoni E, Benedetti F, Minasyan A, Desbuisson M, Cunnea P, Grimm AJ, et al. Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer. Cancer Cell. 2025;43(8):1568-86.e10.","journal-title":"Cancer Cell"},{"key":"850_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030937","author":"I Giacomini","year":"2020","unstructured":"Giacomini I, Ragazzi E, Pasut G, Montopoli M. The pentose phosphate pathway and its involvement in Cisplatin resistance. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21030937.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"850_CR9","first-page":"1","volume":"1868","author":"A Morandi","year":"2017","unstructured":"Morandi A, Indraccolo S. Linking metabolic reprogramming to therapy resistance in cancer. Biochimica et Biophysica Acta (BBA). 2017;1868(1):1\u20136.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"850_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.794962","volume":"8","author":"M Xia","year":"2021","unstructured":"Xia M, Liu D, Liu H, Zhao J, Tang C, Chen G, et al. Based on network pharmacology tools to investigate the mechanism of Tripterygium wilfordii against IgA nephropathy. Front Med (Lausanne). 2021;8:794962.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"850_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/mmr.2014.2191","volume":"10","author":"X Wang","year":"2014","unstructured":"Wang X, Zhang L, Duan W, Liu B, Gong P, Ding Y, et al. Anti-inflammatory effects of triptolide by inhibiting the NF-\u03baB signalling pathway in LPS-induced acute lung injury in a murine model. Mol Med Rep. 2014;10(1):447\u201352.","journal-title":"Mol Med Rep"},{"issue":"5","key":"850_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/CAD.0000000000000894","volume":"31","author":"H Hu","year":"2020","unstructured":"Hu H, Zhu S, Tong Y, Huang G, Tan B, Yang L. Antitumor activity of triptolide in SKOV3 cells and SKOV3\/DDP in vivo and in vitro. Anticancer Drugs. 2020;31(5):483\u201391.","journal-title":"Anticancer Drugs"},{"issue":"14","key":"850_CR13","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.7150\/jca.16178","volume":"7","author":"H Hu","year":"2016","unstructured":"Hu H, Luo L, Liu F, Zou D, Zhu S, Tan B, et al. Anti-cancer and sensibilisation effect of triptolide on human epithelial ovarian cancer. J Cancer. 2016;7(14):2093\u20139.","journal-title":"J Cancer"},{"issue":"6","key":"850_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MOP.0b013e32835a1ac8","volume":"24","author":"JC Madan","year":"2012","unstructured":"Madan JC, Farzan SF, Hibberd PL, Karagas MR. Normal neonatal microbiome variation in relation to environmental factors, infection and allergy. Curr Opin Pediatr. 2012;24(6):753\u20139.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"850_CR15","doi-asserted-by":"publisher","first-page":"586s","DOI":"10.3945\/ajcn.112.039644","volume":"98","author":"AJ Nauta","year":"2013","unstructured":"Nauta AJ, Ben Amor K, Knol J, Garssen J, van der Beek EM. Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. Am J Clin Nutr. 2013;98(2):586s-s593.","journal-title":"Am J Clin Nutr"},{"key":"850_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202505670","author":"X Hou","year":"2025","unstructured":"Hou X, Zhang Z, Chen W, Li J, Zhu X, Li M, et al. MegasphaeraElesdenii dysregulates colon epithelial homeostasis, aggravates colitis-associated tumorigenesis. Adv Sci (Weinh). 2025. https:\/\/doi.org\/10.1002\/advs.202505670.","journal-title":"Adv Sci (Weinh)"},{"issue":"6371","key":"850_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104\u20138.","journal-title":"Science"},{"issue":"3","key":"850_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170(3):548-63.e16.","journal-title":"Cell"},{"issue":"1","key":"850_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40425-019-0561-9","volume":"7","author":"MB Abid","year":"2019","unstructured":"Abid MB. Could the menagerie of the gut microbiome really cure cancer? Hope or hype. J Immunother Cancer. 2019;7(1):92.","journal-title":"J Immunother Cancer"},{"key":"850_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01050","volume":"10","author":"W Ma","year":"2019","unstructured":"Ma W, Mao Q, Xia W, Dong G, Yu C, Jiang F. Gut microbiota shapes the efficiency of cancer therapy. Front Microbiol. 2019;10:1050.","journal-title":"Front Microbiol"},{"key":"850_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1236272","volume":"13","author":"X Zhan","year":"2023","unstructured":"Zhan X, Zuo Q, Huang G, Qi Z, Wang Y, Zhu S, et al. Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer. Front Cell Infect Microbiol. 2023;13:1236272.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"850_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2982.2011.01865.x","volume":"24","author":"S Agostini","year":"2012","unstructured":"Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, L\u00e9v\u00e8que M, et al. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil. 2012;24(4):376-e172.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"850_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","volume":"69","author":"JM Natividad","year":"2013","unstructured":"Natividad JM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res. 2013;69(1):42\u201351.","journal-title":"Pharmacol Res"},{"key":"850_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101928","volume":"42","author":"T Hong","year":"2021","unstructured":"Hong T, Lei G, Chen X, Li H, Zhang X, Wu N, et al. PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer. Redox Biol. 2021;42:101928.","journal-title":"Redox Biol"},{"issue":"9","key":"850_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05257-y","volume":"13","author":"S Tang","year":"2022","unstructured":"Tang S, Shen Y, Wei X, Shen Z, Lu W, Xu J. Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer. Cell Death Dis. 2022;13(9):826.","journal-title":"Cell Death Dis"},{"issue":"5","key":"850_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"850_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04324-3","author":"AAM Abdelgawwad El-Sehrawy","year":"2025","unstructured":"Abdelgawwad El-Sehrawy AAM, Al-Dulaimi AA, Alkhathami AG, S RJ, Panigrahi R, Pargaien A, et al. Nrf2 as a ferroptosis gatekeeper in colorectal cancer: implications for therapy. Naunyn-Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-04324-3.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"850_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13(1):76\u201386.","journal-title":"Genes Dev"},{"issue":"3","key":"850_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.14348\/molcells.2023.0028","volume":"46","author":"T Suzuki","year":"2023","unstructured":"Suzuki T, Takahashi J, Yamamoto M. Molecular basis of the KEAP1-NRF2 signalling pathway. Mol Cells. 2023;46(3):133\u201341.","journal-title":"Mol Cells"},{"issue":"30","key":"850_CR30","volume":"12","author":"ZW Chen","year":"2025","unstructured":"Chen ZW, Shan JJ, Chen M, Wu Z, Zhao YM, Zhu HX, et al. Targeting GPX4 to induce ferroptosis overcomes chemoresistance mediated by the PAX8-AS1\/GPX4 axis in intrahepatic cholangiocarcinoma. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2025;12(30):e01042.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"850_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2221093","volume":"15","author":"X Hu","year":"2023","unstructured":"Hu X, Xu X, Zeng X, Jin R, Wang S, Jiang H, et al. Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signalling pathway. Gut Microbes. 2023;15(1):2221093.","journal-title":"Gut Microbes"},{"key":"850_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215178","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wei X, Li W, Ma Y, Chen G, Zhao L, et al. Endogenous Propionibacterium acnes promotes ovarian cancer progression via regulating Hedgehog signalling pathway. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14215178.","journal-title":"Cancers"},{"issue":"8","key":"850_CR33","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"850_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie PJ, Holmes S. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217.","journal-title":"PLoS One"},{"issue":"6","key":"850_CR35","first-page":"230","volume":"33","author":"ME Day","year":"1971","unstructured":"Day ME. A survey of methods used in the histochemical investigation of mucopolysaccharides. Can J Med Technol. 1971;33(6):230\u201342.","journal-title":"Can J Med Technol"},{"issue":"2","key":"850_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/43.2.7822775","volume":"43","author":"SR Shi","year":"1995","unstructured":"Shi SR, Imam SA, Young L, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem. 1995;43(2):193\u2013201.","journal-title":"J Histochem Cytochem"},{"key":"850_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/978-1-0716-2780-8_26","volume":"2588","author":"HM Hussaini","year":"2023","unstructured":"Hussaini HM, Seo B, Rich AM. Immunohistochemistry and immunofluorescence. Methods Mol Biol (Clifton, NJ). 2023;2588:439\u201350.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"2","key":"850_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1083\/jcb.9.2.409","volume":"9","author":"JH Luft","year":"1961","unstructured":"Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol. 1961;9(2):409\u201314.","journal-title":"J Biophys Biochem Cytol"},{"key":"850_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194702","author":"W Hirose","year":"2022","unstructured":"Hirose W, Oshikiri H, Taguchi K, Yamamoto M. The KEAP1-NRF2 system and esophageal cancer. Cancers. 2022. https:\/\/doi.org\/10.3390\/cancers14194702.","journal-title":"Cancers"},{"key":"850_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.toxlet.2019.05.001","volume":"311","author":"L Zhang","year":"2019","unstructured":"Zhang L, Xia Q, Zhou Y, Li J. Endoplasmic reticulum stress and autophagy contribute to cadmium-induced cytotoxicity in retinal pigment epithelial cells. Toxicol Lett. 2019;311:105\u201313.","journal-title":"Toxicol Lett"},{"issue":"1","key":"850_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2013.05.038","volume":"337","author":"EA Runkle","year":"2013","unstructured":"Runkle EA, Mu D. Tight junction proteins: from barrier to tumorigenesis. Cancer Lett. 2013;337(1):41\u20138.","journal-title":"Cancer Lett"},{"issue":"9","key":"850_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046399","volume":"7","author":"J Dicksved","year":"2012","unstructured":"Dicksved J, Schreiber O, Willing B, Petersson J, Rang S, Phillipson M, et al. <Text>Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction<\/Text>. PLoS One. 2012;7(9):e46399.","journal-title":"PLoS One"},{"key":"850_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.842153","volume":"10","author":"KK Wang","year":"2022","unstructured":"Wang KK, He KY, Yang JY, Liu MJ, Guo JR, Liang JY, et al. <Text>Lactobacillus suppresses tumorigenesis of oropharyngeal cancer via enhancing anti-tumor immune response<\/Text>. Front Cell Dev Biol. 2022;10:842153.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"850_CR44","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH, et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023;186(9):1846-62.e26.","journal-title":"Cell"},{"key":"850_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09249-8","author":"NY Lin","year":"2025","unstructured":"Lin NY, Fukuoka S, Koyama S, Motooka D, Tourlousse DM, Shigeno Y, et al. <Text>Microbiota-driven antitumour immunity mediated by dendritic cell migration<\/Text>. Nature. 2025. https:\/\/doi.org\/10.1038\/s41586-025-09249-8.","journal-title":"Nature"},{"issue":"1","key":"850_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40170-025-00391-5","volume":"13","author":"S Deng","year":"2025","unstructured":"Deng S, Kim W, Cheng K, Yang Q, Singh Y, Bae G, et al. <Text>Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer<\/Text>. Cancer Metab. 2025;13(1):21.","journal-title":"Cancer Metab"},{"issue":"10","key":"850_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/stem.3051","volume":"37","author":"I Kareva","year":"2019","unstructured":"Kareva I. <Text>Metabolism and gut microbiota in cancer immunoediting, CD8\/Treg ratios, immune cell homeostasis, and cancer (immuno)therapy: concise review<\/Text>. Stem Cells. 2019;37(10):1273\u201380.","journal-title":"Stem Cells"},{"issue":"8","key":"850_CR48","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1470-2045(19)30340-7","volume":"20","author":"NR Nen\u00e9","year":"2019","unstructured":"Nen\u00e9 NR, Reisel D, Leimbach A, Franchi D, Jones A, Evans I, et al. <Text>Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study<\/Text>. Lancet Oncol. 2019;20(8):1171\u201382.","journal-title":"Lancet Oncol"},{"issue":"1","key":"850_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13287-025-04246-0","volume":"16","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang SH, Liu T, Xie GS, Deng SH, Zhang T, et al. <Text>Golgicide A induces pyroptosis of lung cancer stem cells by regulating dTGN formation via GOLPH3\/MYO18A complex<\/Text>. Stem Cell Res Ther. 2025;16(1):121.","journal-title":"Stem Cell Res Ther"},{"issue":"44","key":"850_CR50","doi-asserted-by":"publisher","first-page":"45495","DOI":"10.1074\/jbc.M406933200","volume":"279","author":"H Yamaguchi","year":"2004","unstructured":"Yamaguchi H, Wang HG. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem. 2004;279(44):45495\u2013502.","journal-title":"J Biol Chem"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00850-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:02:04Z","timestamp":1777424524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-025-00850-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00850-3","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal-related procedures were conducted in strict accordance with the ethical standards outlined by the International Council for Laboratory Animal Science (ICLAS) and were specifically approved by the Experimental Animal Ethics Committee of Nanchang University Health Science Centre (Approval No. NCULAE-20221031115; Approval Date: July 1, 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}